ClinicalTrials.gov
public full text
Public Domain
Safety Study of Foretinib (GSK1363089) in Adults With Liver Cancer
The purpose of this study is to assess the safety and tolerability of foretinib (also known as GSK1363089) when used in the treatment of patients with advanced hepatocellular carcinoma (liver cancer).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer#1171601
- Study of GSK1363089 in Metastatic Gastric Cancer#1163799
- A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors#911509
- Trial of TRC105 and Sorafenib in Patients With HCC#811884
- Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia#980570
Record · ID 1151045
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive